Q3 2025 Earnings Call October 21, 2025 9:00 AM EDTCompany ParticipantsChinmay Trivedi - Senior Vice President of Investor ...
SIGNAL-AA Part B exceeded target enrollment based on demand from patients; trial size increased to 33 patients -- WALTHAM, Mass., Oct. 21, 2025 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), ...
Evaluating the advantages and potential drawbacks of shielding as a method for safe RL. Bettina Könighofer is an assistant professor at Graz University of Technology, Graz, Austria. Roderick Bloem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results